This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Technology Will Set Health Reform Free

Khosla writes that in just a few years their customers will be able to buy "digital first aid kits" for just $100 with apps that monitor "blood pressure, A1c levels, ECG waveforms, blood oxygen levels, skin/ear/ENT conditions, social interaction, and other indicators of how well patients are managing their diabetes, asthma, depression, and other chronic conditions." Drug stores would then become "healthcare service stations" where the data can be analyzed and people given real care at low cost.

How good are these software programs? Indiana University researchers say modern predictive modeling can cut costs by 50% and improve patient outcomes by 40%. The Journal of the Medical Information Association says up to 25% of key data in doctors' notes isn't being acted on, sometimes for as long as two years, delaying diagnoses like cancer, heart attack and other life-threatening conditions. Getting these "machine" conclusions before doctors at the point of treatment will speed care and save lives, the journal writes. So will getting them into the hands of nurses and pharmacists, I might add.

Despite all the efforts to stymie health reform, in other words, technology is coming. Patients with access to monitoring, who can get data analyzed, live longer and cost the system less. The opportunities are just now coming into focus, and whether real reform comes from Washington, Wall Street, or Silicon Valley, it's going to happen.

At the time of publication, the author was long MSFT and GOOG.

This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
WAG $81.65 2.05%
CERN $55.31 0.00%
CVS $93.10 0.00%
GOOG $683.57 0.00%
MCK $154.36 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs